Article ID Journal Published Year Pages File Type
2480636 European Journal of Pharmaceutical Sciences 2014 7 Pages PDF
Abstract

•Molecular structure determined.•Molecular descriptors are calculated based on above structure determination.•SPA and GA as feature selection method coupled with LDA (linear) and KNN (nonlinear) applied and compared.•QSAR classification models were built with linear and nonlinear techniques (only when few descriptors selected).•The SPA was found to select few variables leading to good classification models.

Chalcones are naturally occurring aromatic ketones, which consist of an α-, β-unsaturated carbonyl system joining two aryl rings. These compounds are reported to exhibit several pharmacological activities, including antiparasitic, antibacterial, antifungal, anticancer, immunomodulatory, nitric oxide inhibition and anti-inflammatory effects. In the present work, a Quantitative Structure–Activity Relationship (QSAR) study is carried out to classify chalcone derivatives with respect to their antileishmanial activity (active/inactive) on the basis of molecular descriptors. For this purpose, two techniques to select descriptors are employed, the Successive Projections Algorithm (SPA) and the Genetic Algorithm (GA). The selected descriptors are initially employed to build Linear Discriminant Analysis (LDA) models. An additional investigation is then carried out to determine whether the results can be improved by using a non-parametric classification technique (One Nearest Neighbour, 1NN). In a case study involving 100 chalcone derivatives, the 1NN models were found to provide better rates of correct classification than LDA, both in the training and test sets. The best result was achieved by a SPA–1NN model with six molecular descriptors, which provided correct classification rates of 97% and 84% for the training and test sets, respectively.

Graphical abstractFigure optionsDownload full-size imageDownload high-quality image (70 K)Download as PowerPoint slide

Related Topics
Health Sciences Pharmacology, Toxicology and Pharmaceutical Science Drug Discovery
Authors
, , , , ,